The Promise of Psychedelic Research with Dr. Stephen Bright
In this episode, I talk to Dr. Stephen Bright about the latest in psychedelic research.
Guest Bio:
Dr. Stephen Bright is a leading voice on psychedelic research and drug policy in Australia.
Stephen is a clinically-trained psychologist, though he identifies as an ethnopharmacologist (i.e, a person who studies the human relationship with drugs). He is a leading Australian voice on the role of drug policy on emerging drug trends such as synthetic cannabis and darkweb marketplaces.
Shownotes:
0:00-3:09: Welcome, opening remarks, Dr. Stephen Bright’s bio.
3:09-7:10: Steve’s background in psychedelic research
7:10-12:45: How MDMA & other psychedelics can help treat trauma
12:45-18:42: Psychedelics (Entheogens) & Spiritual Experiences
18:42-23:23: Integrating psychedelic experiences
23:23-34:23: What distinguishes MDMA from other psychedelics
34:23-40:10: Obstacles to psychedelic research in Australia
40:10-47:05: Consideration of the relative toxicity of alcohol, psychedelics and opiates
47:05-51:14: Upcoming events and contact info for Dr. Bright
Links:
PRISM
How To Find Dr. Stephen Bright:
Please help us get the word out by:
Sharing this interview with friends and on your social media platforms
Writing a review for the podcast on iTunes, Sticher or the Google Music Store